These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability. Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850 [TBL] [Abstract][Full Text] [Related]
3. Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa. Köhler T; Dumas JL; Van Delden C Antimicrob Agents Chemother; 2007 Dec; 51(12):4243-8. PubMed ID: 17876004 [TBL] [Abstract][Full Text] [Related]
4. Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. Tateda K; Ishii Y; Hirakata Y; Matsumoto T; Ohno A; Yamaguchi K J Antimicrob Chemother; 1994 Dec; 34(6):931-42. PubMed ID: 7730236 [TBL] [Abstract][Full Text] [Related]
5. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Champlin FR; Ellison ML; Bullard JW; Conrad RS Int J Antimicrob Agents; 2005 Aug; 26(2):159-164. PubMed ID: 16040235 [TBL] [Abstract][Full Text] [Related]
6. High temperature induced antibiotic sensitivity changes in Pseudomonas aeruginosa. Bhatti AR; Kumar K; Stobo C; Chaudhry GR; Ingram JM Microbios; 1999; 97(387):103-15. PubMed ID: 10453485 [TBL] [Abstract][Full Text] [Related]
7. Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan. Ellison ML; Champlin FR Vet Microbiol; 2007 Oct; 124(3-4):310-8. PubMed ID: 17560745 [TBL] [Abstract][Full Text] [Related]
8. Alteration of susceptibility to EDTA, polymyxin B and gentamicin in Pseudomonas aeruginosa by divalent cation regulation of outer membrane protein H1. Nicas TI; Hancock RE J Gen Microbiol; 1983 Feb; 129(2):509-17. PubMed ID: 6302204 [TBL] [Abstract][Full Text] [Related]
9. Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan. Ellison ML; Roberts AL; Champlin FR FEMS Microbiol Lett; 2007 Apr; 269(2):295-300. PubMed ID: 17263842 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics. Werneburg M; Zerbe K; Juhas M; Bigler L; Stalder U; Kaech A; Ziegler U; Obrecht D; Eberl L; Robinson JA Chembiochem; 2012 Aug; 13(12):1767-75. PubMed ID: 22807320 [TBL] [Abstract][Full Text] [Related]
11. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215 [TBL] [Abstract][Full Text] [Related]
12. A peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa. Mori N; Ishii Y; Tateda K; Kimura S; Kouyama Y; Inoko H; Mitsunaga S; Yamaguchi K; Yoshihara E J Antimicrob Chemother; 2012 Sep; 67(9):2173-81. PubMed ID: 22628248 [TBL] [Abstract][Full Text] [Related]
13. New antimicrobial peptide-antibiotic combination strategy for Pseudomonas aeruginosa inactivation. Han W; Wei Z; Camesano TA Biointerphases; 2022 Aug; 17(4):041002. PubMed ID: 35922283 [TBL] [Abstract][Full Text] [Related]
14. Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Wagner T; Soong G; Sokol S; Saiman L; Prince A Chest; 2005 Aug; 128(2):912-9. PubMed ID: 16100186 [TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Okamoto K; Gotoh N; Nishino T Antimicrob Agents Chemother; 2001 Jul; 45(7):1964-71. PubMed ID: 11408209 [TBL] [Abstract][Full Text] [Related]
16. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Halldorsson S; Gudjonsson T; Gottfredsson M; Singh PK; Gudmundsson GH; Baldursson O Am J Respir Cell Mol Biol; 2010 Jan; 42(1):62-8. PubMed ID: 19372247 [TBL] [Abstract][Full Text] [Related]
17. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Zhang L; Dhillon P; Yan H; Farmer S; Hancock RE Antimicrob Agents Chemother; 2000 Dec; 44(12):3317-21. PubMed ID: 11083634 [TBL] [Abstract][Full Text] [Related]
18. New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides. Sautrey G; Zimmermann L; Deleu M; Delbar A; Souza Machado L; Jeannot K; Van Bambeke F; Buyck JM; Decout JL; Mingeot-Leclercq MP Antimicrob Agents Chemother; 2014 Aug; 58(8):4420-30. PubMed ID: 24867965 [TBL] [Abstract][Full Text] [Related]
19. Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa. Plesiat P; Aires JR; Godard C; Köhler T J Bacteriol; 1997 Nov; 179(22):7004-10. PubMed ID: 9371446 [TBL] [Abstract][Full Text] [Related]
20. Outer membrane proteins and lipopolysaccharide changes after exposure of Pseudomonas aeruginosa to antibacterial drugs. Giordano A; Magni A; Trancassini M; Cipriani P New Microbiol; 1993 Jul; 16(3):281-6. PubMed ID: 8366824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]